Here's the live share price of Entero Healthcare Solutions along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Entero Healthcare Solutions | 7.41 | -0.67 | 16.99 | 18.23 | -12.42 | 3.23 | 1.93 |
| Sun Pharmaceutical Industries | 3.07 | 12.74 | 9.05 | 5.77 | 10.14 | 26.15 | 22.32 |
| Divi's Laboratories | 1.88 | 10.17 | 9.98 | 7.06 | 7.27 | 28.44 | 11.35 |
| Torrent Pharmaceuticals | 3.81 | 6.46 | 5.22 | 19.94 | 37.48 | 38.74 | 26.75 |
| Cipla | 5.56 | 14.00 | 4.44 | -8.37 | -3.68 | 14.84 | 8.67 |
| Dr. Reddy's Laboratories | 4.34 | 7.12 | 3.10 | 5.80 | 7.74 | 13.99 | 4.74 |
| Mankind Pharma | 7.31 | 20.51 | 27.43 | 15.48 | 1.28 | 24.73 | 12.65 |
| Zydus Lifesciences | 10.86 | 11.17 | 15.53 | 12.22 | 17.92 | 27.15 | 11.10 |
| Lupin | 3.30 | -1.72 | 3.11 | 12.70 | 16.48 | 43.46 | 13.69 |
| Aurobindo Pharma | 1.37 | 11.00 | 30.90 | 25.63 | 27.39 | 36.05 | 8.16 |
| Laurus Labs | 6.00 | 20.14 | 33.13 | 37.48 | 128.74 | 63.26 | 23.02 |
| Biocon | 4.13 | 21.34 | 13.30 | 10.06 | 30.73 | 21.90 | 2.55 |
| Glenmark Pharmaceuticals | 4.30 | 6.57 | 16.27 | 26.28 | 65.38 | 57.76 | 31.38 |
| Alkem Laboratories | -0.16 | -3.34 | 1.00 | -4.49 | 3.53 | 18.72 | 12.73 |
| Abbott India | 0.84 | 7.47 | 4.67 | -6.97 | -10.72 | 8.76 | 11.42 |
| Anthem Biosciences | -4.00 | 7.42 | 14.21 | 20.01 | 6.44 | 2.10 | 1.26 |
| Ipca Laboratories | 9.04 | 11.91 | 13.33 | 14.37 | 13.17 | 34.02 | 8.27 |
| Ajanta Pharma | 2.15 | 14.75 | 8.60 | 26.93 | 22.77 | 34.42 | 19.76 |
| GlaxoSmithKline Pharmaceuticals | -2.46 | -3.47 | -9.71 | -6.42 | -15.78 | 21.81 | 9.96 |
| Gland Pharma | 20.14 | 23.50 | 21.69 | 21.97 | 48.12 | 35.36 | -6.88 |
Source: Dion Global
Over the last one year, Entero Healthcare Solutions has declined 12.42% compared to peers like Sun Pharmaceutical Industries (10.14%), Divi's Laboratories (7.27%), Torrent Pharmaceuticals (37.48%). From a 5 year perspective, Entero Healthcare Solutions has underperformed peers relative to Sun Pharmaceutical Industries (22.32%) and Divi's Laboratories (11.35%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,186.49 | 1,208.23 |
| 10 | 1,206.47 | 1,208.85 |
| 20 | 1,222.76 | 1,211.23 |
| 50 | 1,171.84 | 1,188.24 |
| 100 | 1,139.29 | 1,161.89 |
| 200 | 1,137.74 | 1,159.06 |
Source: Dion Global
In the latest quarter, Entero Healthcare Solutions remained same as its previous close in promoter holding, while DII stake increased to 16.62%, FII holding fell to 4.03%, and public shareholding moved up to 26.94% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 15,77,379 | 0.99 | 191.87 | |
| 10,72,913 | 0.22 | 130.51 | |
| 9,40,428 | 1.72 | 114.39 | |
| 2,46,100 | 1.18 | 29.94 | |
| 52,609 | 0.84 | 6.4 | |
| 17,000 | 0.63 | 2.07 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 19, 2026, 12:30 AM IST IST | Entero Healthcare - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements |
| May 07, 2026, 01:00 AM IST IST | Entero Healthcare - Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
| Apr 08, 2026, 09:18 PM IST IST | Entero Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 12, 2026, 01:40 AM IST IST | Entero Healthcare - Announcement under Regulation 30 (LODR)-Change in Management |
| Mar 05, 2026, 01:34 AM IST IST | Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Source: Dion Global
Entero Healthcare Solutions Ltd. is a Public Limited Listed company incorporated on 10/01/2018 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74999HR2018PLC072204 and registration number is 072204. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 408.67 Cr. and Equity Capital is Rs. 43.51 Cr. for the Year ended 31/03/2025.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Entero Healthcare Solutions is ₹1,264.55 as on May 20, 2026.
The Entero Healthcare Solutions is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Entero Healthcare Solutions is ₹5,502.18 Cr as on May 20, 2026.
Today’s highest and lowest price of Entero Healthcare Solutions are ₹1,264.55 and ₹1,221.20.
The 52-week high/low is the highest and lowest price at which Entero Healthcare Solutions stock has traded in the past 52-week or nearly a year. The 52-week high of Entero Healthcare Solutions is ₹1,509.90 and 52-week low of Entero Healthcare Solutions is ₹944.00 as on May 20, 2026.
The Entero Healthcare Solutions has shown returns of 1.77% over the past day, -0.67% for the past month, 16.99% over 3 months, -12.42% over 1 year, 3.23% across 3 years, and 1.93% over 5 years.
P/E ratio of and PB ratio of Entero Healthcare Solutions are 48.81 and 3.06 on May 20, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global